Concepedia

CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia

Maria Alice V. Willrich, Mário Hiroyuki Hirata, Fabiana Dalla Vecchia Genvigir, Simone Sorkin Arazi, Ivanise Marina Moretti Rebecchi, Alice Cristina Rodrigues, Márcia Martins Silveira Bernik, Egı́dio Lima Dórea, Marcelo Chiara Bertolami, André Árpád Faludi,

Clinica Chimica Acta · 2008 · 63 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

William T. Friedewald, Robert I. Levy, Donald S. Fredrickson · Clinical Chemistry · 1972 · 32.5K citations

, , +14

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Peter Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics · 2001 · 2.2K citations

, , +17

The genetic determinants of the CYP3A5 polymorphism

Elisabeth Hustert, Michael Haberl, Oliver Burk et al. · Pharmacogenetics · 2001 · 670 citations

, , +13

Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction

Daniel I. Chasman · JAMA · 2004 · 457 citations

, , +16

CYP3A5 Variant Allele Frequencies in Dutch Caucasians

Ron HN van Schaik, Ilse P. van der Heiden, John N. van den Anker et al. · Clinical Chemistry · 2002 · 303 citations · Full text

, , +15